News about "Alpha-1 Antitrypsin Deficiency"

Sentynl and Mereo Partner on Alvelestat for AATD-Associated Lung Disease

Sentynl and Mereo Partner on Alvelestat for AATD-Associated Lung Disease

Sentynl Therapeutics and Mereo BioPharma have signed an option and license deal for alvelestat, with Sentynl set to commercialise it in the US upon option exercise.

Alpha-1 Antitrypsin Deficiency | 12/08/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members